Meanwhile, compared with the control PD mice, the numbers of TH+ DA neurons were not changed in CCR2−/−PD mice, which was consistent with previous reports in which CCR2 blockade does not prevent striatal dopamine loss in the MPTP-induced PD model (46–48). This evidence concerns the gene CCR2 and Parkinson disease.